Tumor localized agonistic anti-CD40 therapy and beyond

Expert Opin Biol Ther. 2020 Mar;20(3):215-217. doi: 10.1080/14712598.2020.1713084. Epub 2020 Jan 10.

Authors

Mohamed Eltahir¹, Helena Persson^{2

3}, Sara Mangsbo¹

Affiliations

¹ Department of Pharmaceutical Biosciences, Science for Life laboratory, Uppsala University, Sweden.
² Drug Discovery and Development, Science for Life Laboratory, Stockholm, Sweden.
³ School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institute of Technology (KTH), Stockholm, Sweden.

PMID: 31920122
DOI: 10.1080/14712598.2020.1713084

No abstract available

Keywords: CD40; Cancer; Immunotherapy; Monoclonal.

Publication types

Editorial
Research Support, Non-U.S. Gov't